title: Kinetics of endogenous leukotriene B4 and E4 production following injection of the chemotactic peptide FMLP in the rabbit.
abstract: The kinetic profiles of leukotriene B4 (LTB4) and E4 (LTE4) after intravenous administration (30 nmol/kg) of the inflammatory peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) were evaluated in male rabbits. LTB4 and LTE4 reached the maximal concentration of 84.2 +/- 60.0 and 162.2 +/- 51.4 nmol/L (mean +/- s.d.), at 2 and 5 min, respectively. The first elimination phase for LTB4 and LTE4, after FMLP administration, showed an apparent half-life of 24.6 +/- 6.7 and 36.9 +/- 13.0 min, respectively. The area under the blood concentration-time curve (AUC, nmol min/L) of LTB4 and LTE4 was 2178 +/- 1591 and 7627 +/- 3052, respectively. LTE4 and N-ac-LTE4 were the major components excreted in the urine, mostly in the first time interval (0-12 h) of urinary collection after FMLP treatment; 11-trans-LTE4 was recovered in the second interval (12-24 h). Two other more polar compounds, potential metabolites, were recovered in the first interval of urine collection. Knowledge of the kinetic characteristics of endogenously produced leukotrienes may be useful in understanding the role of these eicosanoids in inflammatory and thrombotic disease, as well as in evaluating the efficacy of drugs designed to modulate their production and effect.
authors.affiliation: Istituto di Ricerche Farmacologiche Mario Negri, Department of Vascular Medicine and Pharmacology, Santa Maria Imbaro, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Celardo
authors.forename: G
authors.initials: G
authors.lastname: Dell'Elba
authors.forename: S
authors.initials: S
authors.lastname: Manarini
authors.forename: V
authors.initials: V
authors.lastname: Evangelista
authors.forename: G
authors.initials: G
authors.lastname: de Gaetano
authors.forename: C
authors.initials: C
authors.lastname: Cerletti
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D007231:Infant, Newborn; D007975:Leukotriene B4 / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology; D017999:Leukotriene E4 / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology; D008297:Male; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology*; D011817:Rabbits; D012127:Respiratory Distress Syndrome, Newborn / Q000503:physiopathology
chemical_list: D007975:Leukotriene B4; D009240:N-Formylmethionine Leucyl-Phenylalanine; D017999:Leukotriene E4